Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

ceva sante animale, libourne, france (0000006753) zi la ballastiere,,,33500 libourne,fr - inactivated coxiella burnetii, strain nine mile - ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ - inactivated coxiella burnetii, strain nine mile 72,00 inj.susp 0 - inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) - Αίγες; Βοοειδή - Χρόνοι αναμονής: Βοοειδή 0 Ημέρες Κρέας και εδώδιμοι ιστοί, γάλα; Αίγες 0 Ημέρες Κρέας και εδώδιμοι ιστοί, γάλα

Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

lab. hipra s.a., amer-girona, spain (0000007652) avda la selva, 135,e-17170,amer,es - inactivated rabbit haemorrhagic disease type 2 virus (rhdv2), strain v-1037 - ΕΝΕΣΙΜΟ ΓΑΛΑΚΤΩΜΑ - inactivated rabbit haemorrhagic disease type 2 virus (rhdv2), strain v-1037 70,00 em.inj 0 - inactivated viral vaccines - Κουνέλια - Χρόνοι αναμονής: Κουνέλια 0 Ημέρες Κρέας και εδώδιμοι ιστοί

Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

zoetis belgium s.a., louvain-la-neuve, belgium (0000011199) rue laid burniat 1,1348,louvain-la-neuve,be - inactivated bluetongue virus , serotype 4, strain spa-1/2004 - ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ - btv-4 - inactivated bluetongue virus , serotype 4, strain spa-1/2004 0,00 inj.susp btv-4 - inactivated viral vaccines - Πρόβατα; Βοοειδή - Χρόνοι αναμονής: Βοοειδή 0 Ημέρες Κρέας και εδώδιμοι ιστοί; Πρόβατα 0 Ημέρες Κρέας και εδώδιμοι ιστοί

Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

zoetis belgium s.a., louvain-la-neuve, belgium (0000011199) rue laid burniat 1,1348,louvain-la-neuve,be - inactivated bluetongue virus , serotype 8, strain btv-8/bel2006/02 - ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ - btv-8 - inactivated bluetongue virus , serotype 8, strain btv-8/bel2006/02 0,00 inj.susp btv-8 - inactivated viral vaccines - Βοοειδή; Πρόβατα - Χρόνοι αναμονής: Βοοειδή 0 Ημέρες Κρέας και εδώδιμοι ιστοί; Πρόβατα 0 Ημέρες Κρέας και εδώδιμοι ιστοί

Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

zoetis belgium s.a., louvain-la-neuve, belgium (0000011199) rue laid burniat 1,1348,louvain-la-neuve,be - inactivated mycoplasma hyopneumoniae, strain p-5722-3; inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2b orf2 protein - ΕΝΕΣΙΜΟ ΓΑΛΑΚΤΩΜΑ - inactivated mycoplasma hyopneumoniae, strain p-5722-3 1,50 em.inj 0; inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2b orf2 protein 2,30 em.inj 0 - inactivated viral and inactivated bacterial vaccines - Παχυνόμενοι χοίροι - Χρόνοι αναμονής: Παχυνόμενοι χοίροι 0 Ημέρες Κρέας και εδώδιμοι ιστοί

Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

intervet international bv (boxmer), holland (0000005707) wim de körverstraat 35,5831 an boxmeer,boxmeer,nl - inactivated leptospira l.interrogans serogroup grippotyphosa dadas (strain gr-01-005); inactivated leptospira l.interrogans serogroup australis serovar bratislava (strain as-05-073); inactivated leptospira l.interrogans serogroup icterohaemorrhagiae serovar copenhageni (strain ic-02-001); inactivated leptospira l.interrogans serogroup canicola serovar portland-vere (strain ca-12-000) - ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ - (1+25+200)mg/5ml - inactivated leptospira l.interrogans serogroup grippotyphosa dadas (strain gr-01-005) 650,00 inj.susp 0; inactivated leptospira l.interrogans serogroup australis serovar bratislava (strain as-05-073) 500,00 inj.susp 0; inactivated leptospira l.interrogans serogroup icterohaemorrhagiae serovar copenhageni (strain ic-02-001) 290,00 inj.susp 0; inactivated leptospira l.interrogans serogroup canicola serovar portland-vere (strain ca-12-000) 3550,00 inj.susp 0 - leptospira - Σκύλοι - Χρόνοι αναμονής: Σκύλοι

Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

intervet international bv (boxmer), holland (0000005707) wim de körverstraat 35,5831 an boxmeer,boxmeer,nl - inactivated leptospira l.interrogans serogroup grippotyphosa dadas (strain gr-01-005); inactivated leptospira l.interrogans serogroup australis serovar bratislava (strain as-05-073); inactivated leptospira l.interrogans serogroup icterohaemorrhagiae serovar copenhageni (strain ic-02-001); inactivated leptospira l.interrogans serogroup canicola serovar portland-vere (strain ca-12-000) - ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ - inactivated leptospira l.interrogans serogroup grippotyphosa dadas (strain gr-01-005) 650,00 inj.susp 0; inactivated leptospira l.interrogans serogroup australis serovar bratislava (strain as-05-073) 500,00 inj.susp 0; inactivated leptospira l.interrogans serogroup icterohaemorrhagiae serovar copenhageni (strain ic-02-001) 290,00 inj.susp 0; inactivated leptospira l.interrogans serogroup canicola serovar portland-vere (strain ca-12-000) 3550,00 inj.susp 0 - leptospira - Σκύλοι - Χρόνοι αναμονής: Σκύλοι

Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

laboratorios hipra, s.a. - mycoplasma hyopneumoniae, strain 7304 (nexhyon), expressing the capsid protein of porcine circovirus type 2a, inactivated - immunologicals for suidae, inactivated viral and inactivated bacterial vaccines - Χοίροι - for the active immunisation of pigs:to reduce lung lesions associated with porcine enzootic pneumonia caused by mycoplasma hyopneumoniae. also, to reduce the incidence of these lesions (as observed in field studies). to reduce viraemia, virus load in lungs and lymphoid tissues and the duration of the viraemic period associated with diseases caused by porcine circovirus type 2 (pcv2). efficacy against pcv2 genotypes a, b and d has been demonstrated in field studies. to reduce culling rate and the loss of daily weight gain caused by mycoplasma hyopneumoniae and/or pcv2 related diseases (as observed at 6 months of age in field studies). mycoplasma hyopneumoniae: onset of immunity: 3 weeks after vaccinationduration of immunity: 23 weeks after vaccinationporcine circovirus type 2:onset of immunity: 2 weeks after vaccinationduration of immunity: 22 weeks after vaccinationin addition, a reduction in nasal and faecal shedding and the duration of nasal excretion of pcv2 was demonstrated in animals challenged at 4 weeks and at 22 weeks after vaccination.

Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

laboratorios hipra, s.a. - inactivated rabbit haemorrhagic disease type 2 virus (rhdv2), strainv-1037 - Αδρανοποιημένα εμβόλια ιογενή - Κουνέλια - Για την ενεργητική ανοσοποίηση των κουνελιών από την ηλικία των 30 ημερών για τη μείωση της θνησιμότητας που προκαλείται από το κουνέλι αιμορραγική νόσο τύπου 2 ιός (rhdv2).

Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

sanofi pasteur europe, france (0000011723) 14 espace henry vallee, lyon, 69007 - purified diphteria toxoid; purified tetanus toxoid; inactivated poliovirus vacc type i; inactivated poliovirus vacc type ii; inactivated poliovirus vacc type iii; aluminium hydroxide - ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ - 0,5ml - ineof00246 purified diphteria toxoid 2.000000 iu; ineof00247 purified tetanus toxoid 20.000000 iu; ineof00249 inactivated poliovirus vacc type i 40.000000; ineof00250 inactivated poliovirus vacc type ii 8.000000; ineof00251 inactivated poliovirus vacc type iii 32.000000; 0021645512 aluminium hydroxide 0.350000 mg - diphtheria-poliomyelitis-tetanus